ArticleScientific reports2022

Conventional dose versus dose escalated radiotherapy including high-dose-rate brachytherapy boost for patients with Gleason score 9-10 clinical localized prostate cancer.

Hideya Yamazaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.